BDNF and diffuse intrinsic pontine glioma: In a similar fashion, targeting TrkB, the receptor for BDNF, using the pan-Trk inhibitor entrectinib resulted in decreased tumor growth and increased survival in a diffuse intrinsic pontine glioma model (DIPG) [32].